Choose your country to see the products for your location
D007 Acute Lymphoblastic Leukemia just received an update, with version B1 featuring new probes that increase the coverage of ALL-relevant regions and target genes of emerging interest for ALL.
Effective from 1 January 2025, we will be implementing a price increase of approximately 1.9% on most of our products.
D001 Hereditary Cancer Panel 1 recently received an update, with version D1 featuring several new modified probes, increasing the performance and coverage of the product.
The product pages on our website are in the process of receiving an exciting makeover. So far, we have transitioned the product pages of our IVD-certified products to the new design, but gradually the product pages of our RUO-products will also follow suit.
As part of our upcoming IVDR transition, we are working on a new product description template that will make our product descriptions easier to read, maintain and translate.
MLPA General Protocol and MS-MLPA General Protocol have a fresh design and have undergone significant restructuring to improve user-friendliness.
We have updated our privacy policy to ensure optimal transparency on how we collect and process your personal data
SALSA MLPA Probemix P369 Smith-Magenis, designed for copy number detection of the 17p11.2 and 2q37.3 regions, has just received a major update with several improved or new target and reference probes.
ME030 BWS/RSS has been updated to ensure an even more robust assay output with several improved target and reference probes and a new digestion control probe.
Have you checked out the new version of our digitalMLPA General Protocol? We have summarized the most important changes in this news item.
Join our mailing list to receive the latest information about our products, technologies and website.